Cited by 272Acute Ischemic Stroke ManagementCardiovascular Health and Risk FactorsLipoproteins and Cardiovascular Health

Different Risk Factors for Different Stroke Subtypes: Association of Blood Pressure, Cholesterol, and Antioxidants

Leppälä, Jaana M., Virtamo, Jarmo, Fogelholm, Rainer, Albanes, Demetrius, Heinonen, Olli P.·1999·Stroke

Abstract

Background and Purpose —Blood pressure is an important risk factor for stroke, but the roles of serum total and HDL cholesterol, α-tocopherol, and β-carotene are poorly established. We studied these factors in relation to stroke subtypes. Methods —Male smokers (n=28 519) aged 50 to 69 years without a history of stroke participated in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study, a controlled trial to test the effect of α-tocopherol and β-carotene supplementation on cancer. From 1985 to 1993, a total of 1057 men suffered from primary stroke: 85 had subarachnoid hemorrhage; 112, intracerebral hemorrhage; 807, cerebral infarction; and 53, unspecified stroke. Results —Systolic blood pressure ≥160 mm Hg increased the risk of all stroke subtypes 2.5 to 4-fold. Serum total cholesterol was inversely associated with the risk of intracerebral hemorrhage, whereas the risk of cerebral infarction was raised at concentrations ≥7.0 mmol/L. The risks of subarachnoid hemorrhage and cerebral infarction were lowered with serum HDL cholesterol levels ≥0.85 mmol/L. Pretrial high serum α-tocopherol decreased the risk of intracerebral hemorrhage by half and cerebral infarction by one third, whereas high serum β-carotene doubled the risk of subarachnoid hemorrhage and decreased that of cerebral infarction by one fifth. Conclusions —The risk factor profiles of stroke subtypes differ, reflecting different etiopathology. Because reducing atherosclerotic diseases, including ischemic stroke, by lowering high serum cholesterol is one of the main targets in public health care, further studies are needed to distinguish subjects with risk of hemorrhagic stroke. The performance of antioxidants needs confirmation from clinical trials.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.str.30.12.2535

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Leppälä, J. M., Virtamo, J., Fogelholm, R., Albanes, D., & Heinonen, O. P.
Affiliations
  • From the Department of Public Health, University of Helsinki (J.M.L., O.P.H.), the National Public Health Institute (J.V.), and the Department of Clinical Neurosciences, Helsinki University Central Hospital (R.F.), Helsinki, Finland, and the National Cancer Institute (D.A.), Bethesda, Md.
  • University of Helsinki (FI)
Venue
Stroke
Published
1999-12
Volume
30
Issue
12
Pages
2535-2540
ISSN
  • 0039-2499 (ISSN-L)
  • 1524-4628
OpenAlex
W2987377578
Cited by
272
References
41
Citations by year
2026: 3 · 2025: 6 · 2024: 3 · 2023: 5 · 2022: 9 · 2021: 9 · 2020: 10 · 2019: 8 · 2018: 8 · 2017: 8 · 2016: 9 · 2015: 15 · 2014: 7 · 2013: 15 · 2012: 16
FWCI
5.49
Type
journal article
Language
en
Open access
closed
Locations
  • Stroke (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (n01cn045165-030)
  • National Cancer Institute (N01 CN 45165)
Topics
  • Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Keywords
stroke subtypes, stroke risk factors, systolic blood pressure, total cholesterol, HDL cholesterol, alpha-tocopherol, beta-carotene, subarachnoid hemorrhage, intracerebral hemorrhage, cerebral infarction, hemorrhagic stroke, ischemic stroke, antioxidants, ATBC Study
MeSH terms
Aged, Blood Pressure, Cerebral Infarction, Cholesterol, Follow-Up Studies, Humans, Cholesterol, HDL, Male, Middle Aged, Risk Factors, Smoking, Subarachnoid Hemorrhage, Vitamin E, Controlled Clinical Trials as Topic, beta Carotene, Intracranial Hemorrhages, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review